Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 326,028 | 452,352 | 310,441 | 173,059 | 189,680 |
| Marketable Securities | 305,930 | 192,089 | 348,110 | 478,347 | 507,749 |
| Receivables | 50,282 | 47,784 | 46,128 | 44,571 | 37,874 |
| Inventories | 9,682 | 7,979 | 6,210 | 6,318 | 6,341 |
| TOTAL | $717,616 | $730,213 | $735,735 | $724,421 | $760,250 |
| Non-Current Assets | |||||
| PPE Net | 9,161 | 8,427 | 6,687 | 5,089 | 3,180 |
| Intangibles | 1,108 | 1,477 | 1,846 | 2,215 | 2,585 |
| Other Non-Current Assets | 54,731 | 55,547 | 15,381 | 15,725 | 17,168 |
| TOTAL | $65,000 | $65,451 | $23,914 | $23,029 | $22,933 |
| Total Assets | $782,616 | $795,664 | $759,649 | $747,450 | $783,183 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,493 | 3,471 | 6,466 | 6,623 | 7,222 |
| Accrued Expenses | 97,474 | 88,385 | 79,956 | 93,118 | 67,604 |
| TOTAL | $105,967 | $91,856 | $86,422 | $99,741 | $74,826 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 49,640 | 48,941 | 10,214 | 9,327 | 9,222 |
| TOTAL | $49,640 | $48,941 | $10,214 | $9,327 | $9,222 |
| Total Liabilities | $155,607 | $140,797 | $96,636 | $109,068 | $84,048 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 160,048 | 158,978 | 157,681 | 155,724 | 155,340 |
| Common Shares | 16 | 16 | 15 | 15 | 15 |
| Retained earnings | -1,985,706 | -1,918,946 | -1,834,286 | -1,792,145 | -1,704,122 |
| Other shareholders' equity | 36 | 509 | 1,480 | 1,525 | 297 |
| TOTAL | $627,009 | $654,867 | $663,013 | $638,382 | $699,135 |
| Total Liabilities And Equity | $782,616 | $795,664 | $759,649 | $747,450 | $783,183 |